Cited by 350Genetic Associations and EpidemiologyCardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis

Open access
Dale, Caroline E., Fatemifar, Ghazaleh, Palmer, Tom M., White, Jon, Prieto-Merino, David, Zabaneh, Delilah, Engmann, Jorgen E.L., Shah, Tina +35 more·2017·Circulation

Abstract

Background: The implications of different adiposity measures on cardiovascular disease etiology remain unclear. In this article, we quantify and contrast causal associations of central adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjBMI]) and general adiposity (body mass index [BMI]) with cardiometabolic disease. Methods: Ninety-seven independent single-nucleotide polymorphisms for BMI and 49 single-nucleotide polymorphisms for WHRadjBMI were used to conduct Mendelian randomization analyses in 14 prospective studies supplemented with coronary heart disease (CHD) data from CARDIoGRAMplusC4D (Coronary Artery Disease Genome-wide Replication and Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics; combined total 66 842 cases), stroke from METASTROKE (12 389 ischemic stroke cases), type 2 diabetes mellitus from DIAGRAM (Diabetes Genetics Replication and Meta-analysis; 34 840 cases), and lipids from GLGC (Global Lipids Genetic Consortium; 213 500 participants) consortia. Primary outcomes were CHD, type 2 diabetes mellitus, and major stroke subtypes; secondary analyses included 18 cardiometabolic traits. Results: Each one standard deviation (SD) higher WHRadjBMI (1 SD≈0.08 U) associated with a 48% excess risk of CHD (odds ratio [OR] for CHD, 1.48; 95% confidence interval [CI], 1.28–1.71), similar to findings for BMI (1 SD≈4.6 kg/m 2 ; OR for CHD, 1.36; 95% CI, 1.22–1.52). Only WHRadjBMI increased risk of ischemic stroke (OR, 1.32; 95% CI, 1.03–1.70). For type 2 diabetes mellitus, both measures had large effects: OR, 1.82 (95% CI, 1.38–2.42) and OR, 1.98 (95% CI, 1.41–2.78) per 1 SD higher WHRadjBMI and BMI, respectively. Both WHRadjBMI and BMI were associated with higher left ventricular hypertrophy, glycemic traits, interleukin 6, and circulating lipids. WHRadjBMI was also associated with higher carotid intima-media thickness (39%; 95% CI, 9%–77% per 1 SD). Conclusions: Both general and central adiposity have causal effects on CHD and type 2 diabetes mellitus. Central adiposity may have a stronger effect on stroke risk. Future estimates of the burden of adiposity on health should include measures of central and general adiposity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.116.026560

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiometabolic disease, cancer, and death.

    “Obesity, characterized by excessive body fat, constitutes a major risk factor for the development of type 2 diabetes (T2D), dyslipidemia, cardiometabolic disease1, cancer2, and overall mortality3.”

    From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [1]

    Experimental — accuracy not yet measured
  • MR is being widely applied to quantitative traits with the aim of discovering modifiable risk factors for disease that are causal and amenable to therapeutic modification.

    “With increasing availability of large-scale phenotyping (and genotyping), MR is being widely applied to quantitative traits (e.g. markers or adiposity, such as body mass index 13-16 ; blood lipids such as HDL-cholesterol 17-19 ; inflammation-related proteins such as interleukin-6 receptor 20,21 12 ) with the aim of discovering modifiable risk factors for disease that are causal and amenable to the”
  • HDL cholesterol MRs do not provide evidence of causation, once unbalanced horizontal pleiotropy is taken into account.

    “HDL cholesterol 17,19 MRs do not provide evidence of causation, once unbalanced horizontal pleiotropy is taken into account”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dale, C. E., Fatemifar, G., Palmer, T. M., White, J., Prieto-Merino, D., Zabaneh, D., Engmann, J. E. L., Shah, T., Wong, A., Warren, H. R., McLachlan, S., Trompet, S., Moldovan, M., Morris, R. W., Sofat, R., Kumari, M., Hyppönen, E., Jefferis, B. J., Gaunt, T. R., Ben-Shlomo, Y., Zhou, A., Gentry-Maharaj, A., Ryan, A., Mutsert, R. D., Noordam, R., Caulfield, M. J., Jukema, J. W., Worrall, B. B., Munroe, P. B., Menon, U., Power, C., Kuh, D., Lawlor, D. A., Humphries, S. E., Mook-Kanamori, D. O., Sattar, N., Kivimaki, M., Price, J. F., Davey Smith, G., Dudbridge, F., Hingorani, A. D., Holmes, M. V., & Casas, J. P.
Affiliations
  • Farr Institute (GB)
  • From Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, United Kingdom (C.E.D., G.F., D.P.-M., A.D.H., J.P.C.); Department of Mathematics and Statistics, Lancaster University, United Kingdom (T.M.P.); UCLGenetics Institute, University College London, United Kingdom (J.W.); Applied Statistical Methods in Medical Research Group, Universidad Catolica de San Antonio de Murcia, Spain (D.P.-M.); Social Genetic & Developmental Psychiatry,...
Venue
Circulation
Published
2017-06-13
Volume
135
Issue
24
Pages
2373-2388
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2626288726
Cited by
345
References
45
Citations by year
2026: 14 · 2025: 25 · 2024: 34 · 2023: 42 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 45 · 2018: 46 · 2017: 11
FWCI
25.53
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, other-oa)
  • Bristol Research (University of Bristol) (publishedVersion, other-oa)
  • Lancaster EPrints (Lancaster University) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
  • Explore Bristol Research (submittedVersion, other-oa)
Funders
  • Pfizer (RG/10/12/28456, K013351, ET2DS)
  • National Institute for Health and Care Research (NF-SI-0515-10091, MC_UU_12013/1, NF-SI-0512-10113)
  • British Heart Foundation (RG/08/008/25291, K013351, RG/10/12/28456, RG008/08, PG/13/66/30442, SP/13/6/30554)
  • Imperial College London
  • University College London
  • European Commission (602757)
  • Universiteit Leiden
  • ZonMw (91614023)
  • NordForsk (K013351)
  • Leids Universitair Medisch Centrum
  • Medical Research Council (MR/K013351/1, MR/K006584/1, RG/10/12/28456, K013351, MC_UU_12013, MR/N01104X/1, MC_UU_12013/1‐9, MCUU12013/1, MR/N01104X/2, ET2DS)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
adiposity, abdominal obesity, waist-to-hip ratio, body mass index, coronary artery disease, ischemic stroke, type 2 diabetes, cardiometabolic disease, left ventricular hypertrophy, carotid intima-media thickness, circulating lipids, interleukin-6, glycemic traits
MeSH terms
Coronary Disease, Diabetes Mellitus, Type 2, Humans, Longitudinal Studies, Prospective Studies, Stroke, Polymorphism, Single Nucleotide, Adiposity, Body Fat Distribution, Mendelian Randomization Analysis, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review